Pharmac proposes funding two CLL combo therapies in NZ from May 1, 2026, following public consultation.

Pennsylvania Hospital will open as a public museum in May 2026 to celebrate its 275th anniversary with interactive exhibits on its medical history.

Sanofi expands its Hyderabad center to 4,500 employees, boosting R&D and innovation in India.

India's Health Minister urges AIIMS reforms: patient care, AI integration, and faster hiring.

Scientists developed electronic "cyborg" pancreas cells to monitor and boost insulin production in lab-grown islets, advancing diabetes treatment.

A brain training game targeting attention and speed may cut dementia risk by 25% in adults over 65.

Gilead Sciences beat earnings estimates, raised 2026 guidance, and saw stock momentum despite long-term growth questions.

Nanovibronix trails peers in key metrics despite better earnings and lower P/E, with higher volatility and weaker growth outlook.

Gazyva showed strong results in treating primary membranous nephropathy, a kidney disease, potentially becoming the first approved therapy for it.

Nuclera and leadXpro partner to accelerate drug discovery for tough membrane proteins using AI, cell-free synthesis, and cryo-EM.